← Leaderboards

Michael A Teitell

University Of California Los Angeles

Google Scholar ↗PubMed ↗ORCID ↗

$22,516,970

Attributed

$30,585,547

Total exposure

19

Grants

14

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $8.2M · FY2005–25

$10M$7.5M$5M$2.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$77,870,723 · 20

By mechanism

P30$53,643,948 · 7

R01$15,798,934 · 7

T32$6,573,978 · 2

P01$837,797 · 1

R21$760,106 · 2

K08$255,960 · 1

Top collaborators

Most similar at University Of California Los Angeles

Same institution · by research overlap

Carla M. Koehler$14,340,942
Pei-Yu Chiou$1,961,246
Eric Torres$109,434
Meena Garg$323,743
Uday P Devaskar$1,508,834

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsCellsSignal TransductionProgramsAreaTumorGrantComprehensive Cancer CenterCommunitiesLinkInnovationMemberCancer Center Support GrantPathway InteractionsLos AngelesFundingEpigenetic ProcessPreventGenesCountyStrategic PlanningGene ExpressionGeneticMission

Grant awards (117)

Cancer Center Support Grant$5,317,547

P30 · FY2025 · CA · contact PI

Leadership, Planning and Evaluation (LP&E)$908,501

P30 · FY2025 · CA · contact PI

UCLA Tumor Immunology Institutional Training Grant$375,626

T32 · FY2025 · CA · contact PI

Cancer Center Support Grant$196,875

P30 · FY2025 · CA · contact PI

Developmental Funds (Dev Funds)$141,156

P30 · FY2025 · CA · contact PI

Cancer Center Support Grant$85,742

P30 · FY2025 · CA · contact PI

Cancer Center Support Grant$5,266,903

P30 · FY2024 · CA · contact PI

Leadership, Planning and Evaluation$736,116

P30 · FY2024 · CA · contact PI

Cancer Center Support Grant$433,655

P30 · FY2024 · CA · contact PI

UCLA Tumor Immunology Institutional Training Grant$357,202

T32 · FY2024 · CA · contact PI

RNA trafficking in mitochondria$309,649

R01 · FY2024 · GM

Developmental Funds$274,593

P30 · FY2024 · CA · contact PI

Cancer Center Support Grant$200,000

P30 · FY2024 · CA · contact PI

Cancer Center Support Grant$195,000

P30 · FY2024 · CA · contact PI

Cancer Center Support Grant$103,943

P30 · FY2024 · CA · contact PI

Cancer Center Support Grant$5,266,903

P30 · FY2023 · CA · contact PI

Leadership, Planning and Evaluation$736,121

P30 · FY2023 · CA · contact PI

UCLA Tumor Immunology Institutional Training Grant$460,343

T32 · FY2023 · CA · contact PI

SPOTs: Optical Technologies for Instantly Quantifying Multicellular Response Profiles$379,117

R01 · FY2023 · GM

RNA trafficking in mitochondria$310,112

R01 · FY2023 · GM

Developmental Funds$274,597

P30 · FY2023 · CA · contact PI

Cancer Center Support Grant$245,851

P30 · FY2023 · CA · contact PI

Cancer Center Support Grant$199,892

P30 · FY2023 · CA · contact PI

Cancer Center Support Grant$195,000

P30 · FY2023 · CA · contact PI

Cancer Center Support Grant$96,064

P30 · FY2023 · CA · contact PI

Cancer Center Support Grant$5,266,903

P30 · FY2022 · CA · contact PI

Leadership, Planning and Evaluation$736,121

P30 · FY2022 · CA · contact PI

UCLA Tumor Immunology Institutional Traning Grant$536,711

T32 · FY2022 · CA · contact PI

SPOTs: Optical Technologies for Instantly Quantifying Multicellular Response Profiles$379,172

R01 · FY2022 · GM

RNA trafficking in mitochondria$310,261

R01 · FY2022 · GM

Developmental Funds$274,597

P30 · FY2022 · CA · contact PI

Cancer Center Support Grant$145,523

P30 · FY2022 · CA · contact PI

Cancer Center Support Grant$74,992

P30 · FY2022 · CA · contact PI

Cancer Center Support Grant$5,266,903

P30 · FY2021 · CA · contact PI

Leadership, Planning and Evaluation$736,121

P30 · FY2021 · CA · contact PI

UCLA Tumor Immunology Institutional Traning Grant$569,019

T32 · FY2021 · CA · contact PI

SPOTs: Optical Technologies for Instantly Quantifying Multicellular Response Profiles$379,224

R01 · FY2021 · GM

RNA trafficking in mitochondria$310,337

R01 · FY2021 · GM

Developmental Funds$274,597

P30 · FY2021 · CA · contact PI

Cancer Center Support Grant$249,999

P30 · FY2021 · CA · contact PI

Cancer Center Support Grant$5,266,903

P30 · FY2020 · CA · contact PI

Leadership, Planning and Evaluation$993,115

P30 · FY2020 · CA · contact PI

SPOTs: Optical Technologies for Instantly Quantifying Multicellular Response Profiles$530,374

R01 · FY2020 · GM

UCLA Tumor Immunology Institutional Traning Grant$517,558

T32 · FY2020 · CA · contact PI

Developmental Funds$273,137

P30 · FY2020 · CA · contact PI

(PQ5) Mitochondrial Transfer in Tumor Heterogeneity and Acquired Resistence to Therapy$203,580

R21 · FY2020 · CA · contact PI

Cancer Center Support Grant$175,007

P30 · FY2020 · CA · contact PI

Cancer Center Support Grant$149,995

P30 · FY2020 · CA · contact PI

Cancer Center Support Grant$4,295,192

P30 · FY2019 · CA · contact PI

UCLA Tumor Immunology Institutional Traning Grant$535,117

T32 · FY2019 · CA · contact PI

UCSF Dermatology Training Grant$287,738

T32 · FY2019 · AR

(PQ5) Mitochondrial Transfer in Tumor Heterogeneity and Acquired Resistence to Therapy$169,650

R21 · FY2019 · CA · contact PI

Cancer Center Support Grant$4,295,192

P30 · FY2018 · CA · contact PI

UCLA Tumor Immunology Institutional Traning Grant$497,990

T32 · FY2018 · CA · contact PI

Reverse Mitochondrial Genetics Enabled by Blast$454,465

R01 · FY2018 · GM · contact PI

Cancer Center Support Grant$4,295,192

P30 · FY2017 · CA · contact PI

(PQD5) Mass Profiling Melanoma Responses to Improve Therapy Choices and Prognosis$483,693

R01 · FY2017 · CA · contact PI

Reverse Mitochondrial Genetics Enabled by Blast$452,125

R01 · FY2017 · GM · contact PI

RNA trafficking in mitochondria$291,847

R01 · FY2017 · GM

Reverse Mitochondrial Genetics Enabled by Blast$31,920

R01 · FY2017 · GM · contact PI

(PQD5) Mass Profiling Melanoma Responses to Improve Therapy Choices and Prognosis$483,693

R01 · FY2016 · CA · contact PI

UCLA Tumor Immunology Training Program$482,270

T32 · FY2016 · CA · contact PI

Reverse Mitochondrial Genetics Enabled by Blast$461,167

R01 · FY2016 · GM · contact PI

RNA trafficking in mitochondria$296,867

R01 · FY2016 · GM

(PQD5) Mass Profiling Melanoma Responses to Improve Therapy Choices and Prognosis$483,693

R01 · FY2015 · CA · contact PI

Reverse Mitochondrial Genetics Enabled by Blast$468,051

R01 · FY2015 · GM · contact PI

UCLA Tumor Immunology Training Program$441,837

T32 · FY2015 · CA · contact PI

A Fourth Outcome: DNA Damage and the Differentiation of B Cells$314,884

R01 · FY2015 · CA · contact PI

RNA trafficking in mitochondria$301,740

R01 · FY2015 · GM

CRTC2 in Cellular Development, Function, and Neoplasia$273,031

R01 · FY2015 · CA · contact PI

UCLA Tumor Immunology Training Program$39,503

T32 · FY2015 · CA · contact PI

(PQD5) Mass Profiling Melanoma Responses to Improve Therapy Choices and Prognosis$481,506

R01 · FY2014 · CA · contact PI

UCLA Tumor Immunology Training Program$467,412

T32 · FY2014 · CA · contact PI

RNA trafficking in mitochondria$306,992

R01 · FY2014 · GM

A Fourth Outcome: DNA Damage and the Differentiation of B Cells$305,437

R01 · FY2014 · CA · contact PI

CRTC2 in Cellular Development, Function, and Neoplasia$264,840

R01 · FY2014 · CA · contact PI

UCLA Tumor Immunology Training Program$38,799

T32 · FY2014 · CA · contact PI

UCLA Tumor Immunology Training Program$465,035

T32 · FY2013 · CA · contact PI

A Fourth Outcome: DNA Damage and the Differentiation of B Cells$295,991

R01 · FY2013 · CA · contact PI

RNA trafficking in mitochondria$284,680

R01 · FY2013 · GM

CRTC2 in Cellular Development, Function, and Neoplasia$256,649

R01 · FY2013 · CA · contact PI

Microfluidics-Integrated Photothermal Nanoblade for High-Throughput Large Cargo D$169,078

R21 · FY2013 · EB

UCLA Tumor Immunology Training Program$38,598

T32 · FY2013 · CA · contact PI

UCLA Tumor Immunology Training Program$432,554

T32 · FY2012 · CA · contact PI

A Fourth Outcome: DNA Damage and the Differentiation of B Cells$314,884

R01 · FY2012 · CA · contact PI

RNA trafficking in mitochondria$295,294

R01 · FY2012 · GM

CRTC2 in Cellular Development, Function, and Neoplasia$273,031

R01 · FY2012 · CA · contact PI

Microfluidics-Integrated Photothermal Nanoblade for High-Throughput Large Cargo D$217,798

R21 · FY2012 · EB

Epigenetics Core$181,122

P01 · FY2012 · GM · contact PI

UCLA Tumor Immunology Training Program$30,666

T32 · FY2012 · CA · contact PI

A Fourth Outcome: DNA Damage and the Differentiation of B Cells$314,884

R01 · FY2011 · CA · contact PI

RNA trafficking in mitochondria$295,574

R01 · FY2011 · GM

CRTC2 in Cellular Development, Function, and Neoplasia$273,031

R01 · FY2011 · CA · contact PI

Epigenetics Core$181,122

P01 · FY2011 · GM · contact PI

RNA trafficking in mitochondria$298,835

R01 · FY2010 · GM

TCL1 Oncogene in B Lymphocyte Development and Neoplasia$266,199

R01 · FY2010 · CA · contact PI

Epigenetics Core$182,953

P01 · FY2010 · GM · contact PI

TCL1 Oncogene in B Lymphocyte Development and Neoplasia$266,199

R01 · FY2009 · CA · contact PI

Epigenetics Core$184,800

P01 · FY2009 · GM · contact PI

A NOVEL MECHANISM OF TCL1 TUMORIGENESIS$270,281

R01 · FY2008 · CA · contact PI

TCL1 Oncogene in B Lymphocyte Development and Neoplasia$266,199

R01 · FY2008 · CA · contact PI

Epigenetics Core$107,800

P01 · FY2008 · GM · contact PI

A NOVEL MECHANISM OF TCL1 TUMORIGENESIS$270,281

R01 · FY2007 · CA · contact PI

TCL1 Oncogene in B Lymphocyte Development and Neoplasia$266,199

R01 · FY2007 · CA · contact PI

A NOVEL MECHANISM OF TCL1 TUMORIGENESIS$278,354

R01 · FY2006 · CA · contact PI

TCL1 ONCOGENE IN B LYMPHOCYTE DEVELOPMENT AND NEOPLASIA$261,553

R01 · FY2006 · CA · contact PI

TCL1 ONCOGENE IN B LYMPHOCYTE DEVELOPMENT AND NEOPLASIA$16,068

R01 · FY2006 · CA · contact PI

A NOVEL MECHANISM OF TCL1 TUMORIGENESIS$284,591

R01 · FY2005 · CA

TCL1 ONCOGENE IN B LYMPHOCYTE DEVELOPMENT AND NEOPLASIA$267,847

R01 · FY2005 · CA

TCL1 ONCOGENE IN B LYMPHOCYTE DEVELOPMENT AND NEOPLASIA$8,800

R01 · FY2005 · CA

TCL1 ONCOGENE IN B LYMPHOCYTE DEVELOPMENT AND NEOPLASIA$290,872

R01 · FY2004 · CA

A NOVEL MECHANISM OF TCL1 TUMORIGENESIS$282,747

R01 · FY2004 · CA

TCL1 ONCOGENE IN B LYMPHOCYTE DEVELOPMENT AND NEOPLASIA$267,847

R01 · FY2003 · CA

TCL1 ONCOGENE IN B LYMPHOCYTE DEVELOPMENT AND NEOPLASIA$267,847

R01 · FY2002 · CA

GENES INVOLVED IN AIDS LYMPHOMAGENESIS$85,320

K08 · FY2002 · CA

GENES INVOLVED IN AIDS LYMPHOMAGENESIS$85,320

K08 · FY2001 · CA

GENES INVOLVED IN AIDS LYMPHOMAGENESIS$85,320

K08 · FY2000 · CA